Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Myovant Sciences's Total Inventories for the quarter that ended in Mar. 2022 was $7.2 Mil. Myovant Sciences's Revenue for the
three
months ended in Mar. 2022 was $57.6 Mil.
Myovant Sciences's Inventory-to-Revenue for the quarter that ended in Mar. 2022 was 0.12.
Myovant Sciences's Inventory-to-Revenue for the quarter that ended in Mar. 2022
increased
from Dec. 2021 (0.12) to Dec. 2021 (0.12)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Myovant Sciences's Days Inventory for the
three
months ended in Mar. 2022 was 36.83.
Total Inventories can be measured by Days Sales of Inventory (DSI).
Myovant Sciences's days sales of inventory (DSI) for the
three
months ended in Mar. 2022 was 11.35.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Myovant Sciences's Inventory Turnover for the quarter that ended in Mar. 2022 was 2.48.
Myovant Sciences Inventory-to-Revenue Historical Data
The historical data trend for Myovant Sciences's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Myovant Sciences Annual Data
Trend
Mar16
Mar17
Mar18
Mar19
Mar20
Mar21
Mar22
Inventory-to-Revenue
-
-
-
0.04
0.02
Myovant Sciences Quarterly Data
Jun17
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Inventory-to-Revenue
0.11
0.08
0.07
0.12
0.12
Competitive Comparison
For the Biotechnology subindustry, Myovant Sciences's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Myovant Sciences Inventory-to-Revenue Distribution
For the Biotechnology industry and Healthcare sector, Myovant Sciences's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Myovant Sciences's Inventory-to-Revenue falls into.
Myovant Sciences Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Myovant Sciences's Inventory-to-Revenue for the fiscal year that ended in Mar. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Myovant Sciences's Days Inventory for the
three
months ended in Mar. 2022 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Myovant Sciences Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Myovant Sciences's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Myovant Sciences Ltd is a healthcare company focused on redefining care for women and for men. The company's lead product candidate is relugolix, a once-daily, oral GnRH receptor antagonist. It has three late-stage clinical programs for relugolix in uterine fibroids, endometriosis, and prostate cancer. The company is also developing MVT-602, an oligopeptide kisspeptin-1 receptor agonist, that has completed a Phase 2a study for the treatment of female infertility as part of assisted reproduction.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.5(4.8%) Volume: 344,135 3:40PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:MYOV has been successfully added to your 
